• Cell Counting Kit-8 (CCK-8): Precision Cell Proliferation As

  2026-06-29

  The Cell Counting Kit-8 (CCK-8) streamlines sensitive, quantitative cell proliferation and viability assays, outperforming older tetrazolium-based methods in speed and reliability. This article provides workflow enhancements, troubleshooting tips, and practical guidance on leveraging CCK-8 for robust applications across cancer, immunology, and cytotoxicity research.

• TRIM66 and the Epigenetic Control of Olfactory Receptor Expr

  2026-06-29

  The referenced study uncovers TRIM66 as a pivotal epigenetic repressor that enforces the unique 'one-neuron-one-receptor' rule in olfactory sensory neurons. This work clarifies the molecular basis of monogenic olfactory receptor expression, providing new insights into neuronal identity and gene regulation.

• Inhibiting Kir2.1 Reduces PASMC Proliferation and Migration

  2026-06-28

  This study demonstrates that Kir2.1 potassium channels regulate pulmonary artery smooth muscle cell (PASMC) proliferation and migration through the TGF-β1/SMAD2/3 pathway in pulmonary hypertension models. Targeted inhibition of Kir2.1, particularly with ML133, reveals a potential therapeutic avenue for limiting pulmonary vascular remodeling in pulmonary hypertension.

• Cdk5 Downregulation Reverses Ferroptosis in Hippocampal Stro

  2026-06-27

  This study demonstrates that inhibiting Cdk5 activity reverses ferroptosis in hippocampal neurons after ischemic stroke by modulating the AMPK pathway and microglial polarization. These findings provide mechanistic insight into kinase signaling, neuroinflammation, and iron-dependent cell death, highlighting promising therapeutic targets for neuroprotection.

• Phosbind Acrylamide: Precision Phosphorylation Analysis in M

  2026-06-26

  Explore how Phosbind Acrylamide, a leading phosphate-binding reagent, enables advanced protein phosphorylation analysis in bacterial signaling pathways. This article uniquely bridges biochemical method optimization with new insights into microbial protein phosphorylation dynamics.

• Fenipentol (1-Phenyl-1-pentanol): Integrative Insights for A

  2026-06-26

  Explore Fenipentol, a bioactive compound from Ligusticum chuanxiong, as a pivotal tool for gastrointestinal and cardiovascular research. This article offers in-depth mechanistic analysis, new assay perspectives, and practical protocol guidance beyond standard choleretic applications.

• HyperScript™ Reverse Transcriptase: Advanced cDNA Synthesis

  2026-06-25

  HyperScript™ Reverse Transcriptase empowers researchers with robust RNA-to-cDNA conversion, even when tackling low-abundance transcripts or challenging secondary structures. Its enhanced thermal stability and high template affinity make it a superior choice for accurate qPCR and demanding transcriptomic assays.

• NU7441 (KU-57788): Precision DNA-PK Inhibition in DNA Repair

  2026-06-25

  NU7441 (KU-57788) stands out as a nanomolar, highly selective DNA-PK inhibitor, enabling robust modulation of DNA repair and cell cycle checkpoints in both cancer and neurodegeneration models. APExBIO’s validated supply streamlines experimental workflows, particularly where sensitivity, specificity, and reproducibility are critical.

• X-Gal in Functional Genomics: Beyond Blue-White Screening

  2026-06-24

  Explore the advanced use of X-Gal in functional genomics and sensory biology. This article reveals how 5-bromo-4-chloro-indolyl-β-D-galactopyranoside empowers modern assay design and interprets the latest breakthroughs in olfactory receptor research.

• Palonosetron Hydrochloride in CINV: Mechanisms and Clinical

  2026-06-23

  Ruhlmann and Herrstedt's review details the pharmacologic and clinical advantages of palonosetron hydrochloride as a next-generation 5-HT3 receptor antagonist for chemotherapy-induced nausea and vomiting (CINV). Their synthesis of preclinical and clinical evidence highlights palonosetron's extended efficacy, especially for delayed emesis, and its impact on antiemetic regimen optimization.

• Selective SGLT2 Inhibitors in Cardioprotection: Class Effect

  2026-06-23

  This article analyzes a 2022 study on the cardioprotective effects of selective SGLT2 inhibitors in non-diabetic mouse models of myocardial ischemia/reperfusion injury. The research reveals drug-specific differences in infarct size reduction and underlying mechanisms, with implications for translational diabetes and cardiovascular research.

• Salinomycin: Polyether Ionophore Antibiotic in HCC Research

  2026-06-22

  Salinomycin is a polyether ionophore antibiotic with established anti-cancer activity, especially in hepatocellular carcinoma (HCC) models. Its mechanisms include inhibition of the Wnt/β-catenin pathway and ABC drug transporters, making it a valuable tool for cancer research.

• Melittin: Precision GPCR Modulation in Translational GBM Res

  2026-06-22

  This thought-leadership article explores Melittin’s unique mechanistic and translational value as a bioactive peptide for glioblastoma (GBM) research. Integrating recent breakthroughs in G protein-coupled receptor (GPCR) signaling, lipid metabolism, and apoptosis, it offers actionable guidance for researchers seeking to leverage Melittin for precision signal modulation, particularly in the context of the miR-18a/ALOXE3 axis and ferroptosis resistance. Distinct from standard product summaries, this piece bridges mechanistic insight and experimental strategy, highlighting APExBIO’s Melittin as a next-generation tool for dissecting complex cell signaling pathways in cancer biology.

• ECL Chemiluminescent Substrate Detection Kit (Hypersensitive

  2026-06-21

  The ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) is designed to address the challenge of detecting low-abundance proteins in immunoblotting workflows using nitrocellulose or PVDF membranes. It provides high sensitivity, prolonged signal duration, and is optimized for use with diluted antibodies, making it suitable for research settings requiring robust western blot chemiluminescent detection. This kit should not be used for diagnostic or clinical applications.

• AT13387: Precision Hsp90 Inhibition for Translational Oncolo

  2026-06-20

  Explore how AT13387, a next-generation Hsp90 inhibitor, is redefining precision oncology by bridging mechanistic insight into chaperone inhibition, apoptosis induction, and strategic translational research. This thought-leadership article synthesizes evidence from cancer biology, regulated cell death, and recent advances in DAMP release to provide actionable guidance for translational teams aiming to accelerate bench-to-bedside progress.

16430 records 1/1096 page Next 12345 下5页 Last page